OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DECREASED GUT MICROBIOME TRYPTOPHAN METABOLISM AND SEROTONERGIC SIGNALING IN PATIENTS WITH PERSISTENT MENTAL HEALTH AND GASTROINTESTINAL SYMPTOMS AFTER COVID-19
John W. Blackett, Yiwei Sun, Lawrence J. Purpura, et al.
Clinical and Translational Gastroenterology (2022)
Open Access | Times Cited: 23

Showing 23 citing articles:

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57

Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 21

How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
Don L. Goldenberg
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152455-152455
Closed Access | Times Cited: 9

Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Viruses (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 19

Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials
Sa’ed H. Zyoud
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Gender differences in sequelae from COVID-19 infection
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access

Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics
Grant Talkington, Paresh Kolluru, Timothy E. Gressett, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
Xiaoyang Zhou, Weiyang Sun, Yu Zhang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
Anna Nazarewska, Konrad Lewandowski, Magdalena Kaniewska, et al.
Gastroenterology Review (2023) Vol. 18, Iss. 2, pp. 175-182
Open Access | Times Cited: 7

Effect of gut microbiome on serotonin metabolism: a personalized treatment approach
Kristal Potter, Erysa J. Gayle, Subrata Deb
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2589-2602
Closed Access | Times Cited: 5

Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1

Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1

COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations
Filippo Vernia, Hassan Ashktorab, Nicola Cesaro, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1709-1709
Open Access | Times Cited: 3

Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD+ pathway and SIRT1 activation
Caterina Lonati, Georgy Berezhnoy, Nathan G. Lawler, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 62, Iss. 4, pp. 770-788
Open Access | Times Cited: 3

Efficacy of nutraceuticals (probiotics or prebiotics or synbiotics) in the prevention or treatment of COVID -19: a systematic review and meta-analysis
Anju Pradhan Sinha, Mahalaqua Nazli Khatib, Abhay Gaidhane, et al.
Cogent Food & Agriculture (2024) Vol. 10, Iss. 1
Open Access

Unmasking the mental health scars of COVID-19: A longitudinal investigation of children and adolescents in post-lockdown China
Yue Zhu, Yuenan Yu, Yang Wang, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 275-285
Open Access

Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism
Yoshihiro Yokoyama, Hiroshi Nakase
Elsevier eBooks (2024), pp. 493-498
Closed Access

Microbiota-Gut-Brain Axis in Psychiatry: Focus on Depressive Disorders
I-Ching Wang, Shelly A. Buffington, Ramiro Salas
Current Epidemiology Reports (2024)
Closed Access

Sadness and Anxiety Modify the Relationship Between COVID-19 and Gastrointestinal Symptoms at 6–12 Months of Follow-up
John W. Blackett, Mitchell S.V. Elkind, Sheila M. O’Byrne, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 918-924
Open Access | Times Cited: 1

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
Stefanie Quickert, Andreas Stallmach, Philipp A. Reuken
Deleted Journal (2023) Vol. 18, Iss. 2, pp. 136-142
Open Access

Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association
Kevin Houston, Ankit Patel, Michael Saadeh, et al.
Exploration of Medicine (2023), pp. 157-165
Open Access

Page 1

Scroll to top